It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2016.
2016 | Hyderabad, Telangana, India | ActiveNorwell Pharma Private Limited, a active private limited company, was established on 14 October 2016 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909TG2016PTC112435. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Rachana Jain (Director), Akash Jain (Director). Past directors included Kamal Kishore Jain, Mahaveer Chand Jain. It holds ₹4.50 M open charges and ₹2.53 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Block No 106, Gunfoundry, M/S Mayur Complex, Abids, Hyderabad, Telangana, 500001.
U51909TG2016PTC112435
112435
14 October 2016
₹5.00 M
₹0.50 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Norwell Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rachana Jain | Director | 14 Oct 2016 | Current |
| Akash Jain | Director | 14 Oct 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 May 2020 | Past |
| Pramod Abcsdd | Director | 23 May 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Norwell Pharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 35.92% increase. The company also saw a substantial improvement in profitability, with a 814.26% increase in profit. The company's net worth Soared by an impressive increase of 25.32%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Norwell Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹4,500,000.00
₹2,527,979.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Dec 2020 | Yes Bank Limited | ₹4.50 M | Open |
| 29 Dec 2018 | Others | ₹2.53 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Norwell Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Norwell Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Norwell Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Norwell Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Norwell Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
Progress on A charge registered on 29 Dec 2018 via Charge ID 100232968 with Others was fully satisfied on 20 Jul 2021. was documented.
Progress on A charge with Yes Bank Limited amounted to Rs. 4.50 M with Charge ID 100410944 was registered on 31 Dec 2020. was documented.
Progress on A charge with Others amounted to Rs. 2.53 M with Charge ID 100232968 was registered on 29 Dec 2018. was documented.
Rachana Jain was appointed as a Director was appointed as a Director on 14 Oct 2016 & has been associated with this company since 9 years 1 month . was recorded as a recent event.
The CIN of Norwell Pharma Private Limited is U51909TG2016PTC112435.
Norwell Pharma Private Limited is headquartered at Block No 106, Gunfoundry, M/S Mayur Complex, Abids, Hyderabad, Telangana, 500001.
Norwell Pharma Private Limited was incorporated on 14 October 2016.
The current directors of Norwell Pharma Private Limited are
The primary industry of Norwell Pharma Private Limited is Trade.
Norwell Pharma Private Limited is unlisted.
The authorized capital of Norwell Pharma Private Limited is ₹5.00 M, and the paid-up capital is ₹0.50 M.
The compliance status of Norwell Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX